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Setting: Tuberculosis (TB) and diabetes mellitus (DM) 
clinics at Bowring and Lady Curzon Hospital, a tertiary 
care centre in Bangalore, India.
Obejctive: To assess the feasibility and results of TB-DM 
bidirectional screening.
Methods: A descriptive study conducted from 1 March 
to 30 September 2012, in which all TB patients were as-
sessed for DM and vice versa. Fasting blood glucose val-
ues of ⩾126 mg/dl and 110–125 mg/dl were considered 
as DM and pre-diabetes, respectively. 
Results: Of 510 TB patients, 32 (6.3%) had been previ-
ously diagnosed with DM. Screening among the remain-
ing 478 patients yielded 15 (2.9%) with pre-diabetes and 
15 (2.9%) newly diagnosed cases of DM. A higher preva-
lence of DM was found among patients aged ⩾40 years, 
patients with pulmonary TB and smokers. Of the 47 TB-
DM patients, 45 were enrolled in DM care. Of 1670 DM 
patients followed up in DM clinics, 45 already had TB. 
Among the remaining 1625 patients screened, 152 (9%) 
had symptoms suggestive of TB; two of these were found 
to have the disease. 
Conclusion: Bidirectional screening for DM and TB is fea-
sible and produces a high yield for DM among TB patients. 
The yield of TB among DM patients was low and needs 
future research using new, improved TB diagnostic tools.
With an annual tuberculosis (TB) incidence of 2.2 million cases (range 2.0–2.5 million) and an 
estimated 63 million people living with diabetes melli-
tus (DM), India has the highest TB burden and second 
highest DM burden in the world.1–3 Nearly half of DM 
patients do not know their status, and a further 77 mil-
lion people are estimated to have impaired glucose tol-
erance and are at higher risk of becoming diabetic.2–4
DM is known to increase the risk of active TB ap-
proximately three fold, and contributes to adverse TB 
treatment outcomes such as death, treatment failure 
and relapse.5–6 The World Health Organization (WHO) 
and the International Union Against Tuberculosis and 
Lung Disease (The Union) have launched a new ‘Col-
laborative framework for the care and control of dia-
betes and tuberculosis’, with one of the main activities 
being the routine implementation of bidirectional 
screening of the two diseases.7 Bidirectional screening 
aims at early detection of TB among DM patients and 
vice versa, and assists with an integrated approach to 
the management of the co-morbidity. 
Available data from various sites in India show that 
the prevalence of DM among TB patients ranges from 
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25% to as high as 44%.8–10 A pilot project was initiated 
in India in 2012 to assess the feasibility of bidirec-
tional screening. Bowring and Lady Curzon Hospital, 
Bangalore, the teaching hospital of Bangalore Medical 
College and Research Institute in the South Indian 
State of Karnataka, was one of eight tertiary health fa-
cilities that participated in this pilot project. We report 
on the feasibility and results of bidirectional screening 
of TB and DM at this centre.
METHODS
Design 
This is a descriptive study.
Setting
Bowring and Lady Curzon hospital is a 570-bed multi-
speciality teaching hospital in Bangalore. The out-
patient department caters for an average of 900 patients 
per day. The hospital has a separate TB clinic and a 
DM clinic. TB patients diagnosed at different clinics 
and hospital departments are referred to the TB clinic 
for treatment per the Revised National TB Control Pro-
gramme (RNTCP) guidelines.11 An average of 1000 TB 
patients are treated in the TB clinic each year. The DM 
clinic is open 1 day a week and is visited by an average 
of ∼100 DM patients per week.
Study population
All consecutively diagnosed TB patients aged ⩾15 years 
who attended the hospital’s TB clinic from 1 March to 
30 September 2012 were screened for DM. At the DM 
clinic, all DM patients aged ⩾15 years were screened 
for TB over the same period.
Screening procedures 
The screening procedures and the recording and re-
porting tools used were as per the protocols developed 
for the pilot project. The details of these procedures 
have been described in detail elsewhere.12–13 Brieﬂ y, all 
of the patients at the TB clinic were asked about their 
history of DM. Patients not aware of their status were 
offered random blood glucose (RBG) testing. Venous 
blood samples were collected from the patients and 
blood glucose was tested by the hexokinase method. If 
RBG was ⩾110 mg/dl, the patients were offered fasting 
blood glucose (FBG) testing. The cut-offs used in the 
study were as follows: FBG < 110 mg/dl was consid-
ered normal; FBG 110–125 mg/dl was diagnosed as pre-
diabetes; and FBG ⩾ 126 mg/dl was diagnosed as DM.14 
Patients with known DM and newly diagnosed DM were 
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referred to the diabetes clinic for further management. 
Testing for human immunodeﬁ ciency virus (HIV) in-
fection was offered routinely to TB patients; informa-
tion on HIV status was extracted from the TB registers. 
At the DM clinic, patients were asked whether they 
were under TB treatment. Those who were not were 
asked about speciﬁ c symptoms and signs indicative of 
TB (cough for ⩾2 weeks, prolonged fever, weight loss, 
loss of appetite, enlarged glands). Patients who gave 
an afﬁ rmative answer for any of these symptoms were 
referred to the TB clinic for further evaluation. At the 
TB clinic, these patients underwent investigations in-
cluding sputum smear microscopy, chest radiography 
and other investigations per RNTCP guidelines. Type 
of TB was classiﬁ ed per the national guidelines, which 
are in line with WHO recommendations.11
Data collection and validation
At the TB clinic, an additional TB-DM register was used 
to record data on the following variables: age, sex, cur-
rent smoker (deﬁ ned as a person who had smoked to-
bacco at least once during the last 3 months), residence 
(urban or rural), HIV status, RBG and FBG levels, dates 
of TB diagnosis, RBG and FBG tests and referral and 
enrolment into DM care. At the DM clinic, a separate 
treatment card for each patient was used to record 
data about the patient’s DM history and current DM 
status, screening for TB symptoms, the result of screen-
ing and the result of the investigations. The existing 
staff of the TB and DM clinics in the routine health 
care setting were trained and involved in the study; no 
additional manpower or infrastructure was used. Su-
pervision and site visits were undertaken by staff from 
The Union and the RNTCP during the study, and all 
the records were checked for completeness, consis-
tency and accuracy.
Data analysis and statistics
The individual patient data were double-entered into 
EpiData software, version 3.1 (EpiData Association, 
Odense, Denmark), validated and analysed. The data 
were summarised using frequencies and proportions. 
Differences between groups were compared using the 
χ² test. A P value of <0.05 was considered statistically 
signiﬁ cant. The number needed to test (NNT, deﬁ ned 
as reciprocal proportion of the sum of new DM and pre-
diabetes cases) was calculated, disaggregated by demo-
graphic and clinical characteristics.
Ethics approval
We obtained administrative approval from the head of 
the Bangalore Medical College and Research Institute, 
Bangalore. The entire protocol was reviewed and ap-
proved by the Ethics Advisory Group of The Union.
RESULTS
Screening tuberculosis patients 
for diabetes mellitus
The results of DM screening among TB patients are sum-
marised in Table 1. The median (interquartile range) age 
of the TB patients was 35 (25–45) years. Of 510 TB pa-
tients, 32 (6.3%) had been previously diagnosed with 
DM. Screening among the remaining 478 patients 
yielded 15 (2.9%) and 15 (2.9%) pre-diabetes and new 
DM cases, respectively. Of the 47 known/newly diag-
nosed patients, 45 (96%) were registered at the DM 
clinic for further management. Almost all patients un-
derwent RBG testing within one day of the date of TB 
diagnosis; >95% of the patients eligible for FBG un-
derwent the test within 2 days of the RBG test. 
The demographic and clinical characteristics of TB 
patients associated with DM prevalence are shown in 
Table 2. DM prevalence was signiﬁ cantly higher among 
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TABLE 1 Screening TB patients for DM at Bowring and 
Lady Curzon Hospital, Bangalore, India, March–
September 2012
Indicator n (%)
Patients with TB registered over the study period 510
Patients with a known diagnosis of DM  32 (6.3)
Patients needing to be screened with RBG 478
Patients screened with RBG 478 (100)
Patients with RBG ⩾110 mg/dl 110
Patients screened with FBG 109 (99.1)
Patients with FBG <110  79
Patients with FBG 110–125  15 (2.9)
Patients with FBG ⩾126 mg/dl 
(newly diagnosed with DM)  15 (2.9)
Patients with known or newly diagnosed DM  47 (9.2)
Patients with known and newly diagnosed DM 
referred to DM care  47 (100)
Patients with known or newly diagnosed DM 
reaching DM care  45 (95.7)
TB = tuberculosis; DM = diabetes mellitus; RBG = random blood 
glucose; FBG = fasting blood glucose.
TABLE 2 Characteristics of TB patients screened for 
DM at Bowring and Lady Curzon Hospital, Bangalore, 
India, March–September 2012
Characteristic
Total
TB patients
n
Patients
with DM
n (%) P value
Total 510 47 (9.2)
Age, years
<40 319 12 (3.8) <0.001
⩾40 191 35 (18.3)
Sex 
Male 316 32 (10.1) 0.36
Female 194 15 (7.7)
Residence 
Urban 393 38 (9.7) 0.52
Rural 117  9 (7.7)
Smoking status* 
Smoker 137 23 (16.8) <0.001
Non-smoker 372 23 (6.2)
HIV status
Positive  83  8 (9.6) 0.54
Negative 423 38 (9.0)
Unknown   4  1 (25.0)
Type of TB
Pulmonary 205 30 (14.6) <0.001
Extra-pulmonary 305 17 (5.6)
* Not recorded for one TB patient.
TB = tuberculosis; DM = diabetes mellitus; HIV = human immuno-
deficiency virus.
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TB patients aged ⩾40 years, among smokers, and in patients with 
pulmonary TB (PTB). 
The NNT to ﬁ nd a new case of DM and/or pre-diabetes is sum-
marised in Table 3. The overall NNT in this cohort of TB patients 
was 16. However, the NNT was lower among TB patients aged 
⩾40 years, smokers, and individuals with PTB. 
Screening diabetes mellitus patients 
for tuberculosis
The results of TB screening among DM patients are shown in Ta-
ble 4. Overall, 1670 DM patients were seen at least once during 
this period. Of these, 45 were already known TB patients: 17 new 
smear-positive PTB, 9 new smear-negative PTB, 16 new extra-
pulmonary TB, 1 new-others and 2 treatment after default. Of the 
remaining 1625 patients screened for TB, 152 (9.3%) were found 
to have symptoms suggestive of TB, and they were referred to the 
TB clinic for further evaluation. All those referred reached the TB 
clinic and underwent evaluation. Among the 152 symptomatic 
patients, two new smear-positive TB patients were diagnosed and 
initiated on TB treatment. The NNT to detect one person with 
symptoms suggestive of TB was ∼10, and for detection of one TB 
case it was ∼812.
DISCUSSION
The ﬁ ndings of this study provide important insights into the 
programme management of TB-DM co-morbidity, and have sev-
eral health policy implications. 
First, we implemented bidirectional screening for TB and DM 
using existing resources and staff, thus indicating that this is fea-
sible. Almost all TB patients underwent screening for DM and vice 
versa. One of the primary reasons for the low loss to follow-up 
was the close proximity of the TB and DM clinics. The process of 
screening yielded additional new cases of DM and TB, although 
the NNT to detect one new TB case among DM patients was high 
compared with the NNT to detect DM among TB patients.
Second, about 10% of TB patients attending the TB clinics had 
DM. This is lower than the prevalence reported from other sites in 
South India, where it ranged from 25% to 44%.8–10 It should be 
noted that the median age of our study population was lower 
than that in the other studies, and it is well known that the prev-
alence of diabetes increases with age. The tests and criteria used 
for the diagnosis of DM in our study (RBG followed by FBG) dif-
fered from those used in other studies.8–9 The sensitivity of FBG is 
lower than that of the 75 g oral glucose tolerance test, and this 
may have resulted in underestimation of the true proportion of 
DM in our population. Furthermore, the screening yielded 15 pa-
tients with pre-diabetes who are at higher risk of developing type 
2 DM in the future. These patients could be targeted for counsel-
ling and other preventive services. Another reason is probably the 
higher proportion of extra-pulmonary TB patients observed in our 
study, who are known to have a lower prevalence of DM.15
Third, nearly two thirds of all identiﬁ ed DM patients knew 
their status prior to screening. This could be because of the nature 
of the study setting, i.e., a tertiary care hospital where patients have 
the opportunity to periodically undergo various investigations, 
including those for DM. Given the ease and speed of performing 
DM tests, the results are usually available earlier than those for TB 
tests. This might also have contributed to the higher proportion 
of previously known DM. Nevertheless, the early identiﬁ cation of 
patients with co-morbidity, especially among the newly diagnosed 
cases, helped us to link these patients to appropriate DM care, 
which could lead to improved TB treatment outcomes.
Fourth, nearly 10% of the DM patients screened (at least once 
during the study period) in the DM clinics had symptoms sugges-
tive of TB. This is higher than in the general health facility set-
ting, where it is estimated that ∼2–3% of patients have TB symp-
toms.16–17 However, we found very few TB cases among them. 
While the exact reasons for the low yield are not clear, it could be 
due to the fact that DM patients were managed by individual phy-
sicians at diagnosis, and only after glycaemic control was achieved 
were they referred to DM clinic for periodic visits and collection 
of free drugs. Patients attending DM clinics were therefore more 
likely to have adequate glycaemic control and could thus have 
had a lower risk of having TB.15 The other reason for the low yield 
could be the lack of availability of state-of-the-art diagnostic tools, 
such as nucleic acid ampliﬁ cation tests or culture. Future studies 
should focus on the use of these tools to evaluate whether this 
could increase the yield of TB among screened DM patients.
TABLE 3 Number needed to screen to find a new case of DM and 
pre-diabetes among TB patients at Bowring and Lady Curzon 
Hospital, Bangalore, India, March–September 2012
Characteristic
A
Patients with
unknown
DM status
n
B
New
DM cases
diagnosed
n
C
Pre-diabetes 
cases 
diagnosed
n
NNT
(A/B+C)
Total TB patients 478 15 15 16
Age, years 
<40 312  5  5 31
⩾40 166 10 10  8
Sex
Male 294 10 11 14
Female 184  5  4 20
Residence
Urban 367 12 12 15
Rural 111  3  3 18
Smoking status*
Smoker 122  8  5  9
Non-smoker 355  6 10 22
HIV status
Positive  77  2  1 25
Negative 397 12 14 15
Unknown  4  1  0 40
Type of TB
Pulmonary 184  9  8 11
Extra-pulmonary 294  6  7 23
* Not recorded for one TB patient.
DM = diabetes mellitus; TB = tuberculosis; NNT = number needed to test; HIV = 
h uman immunodeficiency virus.
TABLE 4 Screening of DM patients for TB at Bowring and Lady 
Curzon Hospital, Bangalore, India, March–September 2012
Indicator n (%)
Patients seen in the DM clinic during this period 1670
Patients already diagnosed with TB elsewhere   45
Patients screened at least once for TB symptoms in 
this period 1625
Of those screened, patients with a positive TB 
symptom screen  152 (9.3)
Patients with a positive TB symptom screen referred for 
TB investigations  152
Patients diagnosed with TB after referral for investigations    2 (0.1)
Patients identified with TB (known and new)   47 (2.8)
Patients with TB receiving treatment   47
DM = diabetes mellitus; TB = tuberculosis.
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One limitation of our study was that we were not able to ascer-
tain whether a high FBG in patients with TB was indicative of true 
DM or of infection-induced hyperglycaemia. This requires periodic 
blood glucose testing over the course of TB treatment, which was 
beyond the scope of the current study. Further research is needed 
to ascertain this and the optimum timing of DM screening among 
TB patients. The other related limitation was that we could not 
use a glycosylated haemoglobin test for the diagnosis of DM, and 
this might have led to an under-diagnosis of pre-diabetes and DM. 
However, as the glycosylated haemoglobin test is expensive, its 
use in programme conditions needs further evaluation.
In conclusion, our study showed that bidirectional screening 
for DM and TB was feasible, with a high yield of DM among TB 
patients. Screening TB patients for DM could be an efﬁ cient tool 
for the programme management of TB-DM co-morbidity. The 
yield of TB among DM patients was low and needs future research 
using new, improved TB diagnostic tools. 
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Contexte  :  Dispensaires de tuberculose (TB) et de diabète (DM) à 
l’Hôpital Bowring et Lady Curzon, un centre de soins tertiaires à 
Bangalore, Inde.
Objectif  :  Evaluer la faisabilité et les résultats d’un dépistage bidirec-
tionnel TB-DM.
Méthodes  :  Il s’agit d’une étude descriptive menée entre le 1er mars 
et le 30 septembre 2012 pendant laquelle les patients TB ont fait 
l’objet d’une évaluation pour DM et vice versa. Un glucose sanguin à 
jeun ⩾126 mg/dl et a été considéré comme DM et un glucose sanguin 
à jeun de 110–125 mg/dl comme prédiabète.
Résultats  :  Sur 510 patients TB, 32 (6,3%) avaient été diagnostiqués 
antérieurement comme diabétiques. Le dépistage parmi les 478 pa-
tients TB restants a eu un rendement de 15 sujets prédiabétiques 
(2,9%) et de 15 nouveaux cas de diabète (2,9%). On a trouvé une 
prévalence plus élevée de DM chez les patients de ⩾40 ans, chez les 
patients atteints de TB pulmonaire et chez les fumeurs. Sur 47 patients 
TB-DM, 45 ont été pris en charge pour leur DM. Sur 1670 patients 
DM suivis dans les dispensaires du DM, 45 avaient déjà une TB. Parmi 
les 1625 restants et dépistés, 152 (9%) souffraient de symptômes 
suggestifs de TB, parmi lesquels deux patients souffraient de TB.
Conclusion  :  Le dépistage bidirectionnel pour DM et TB est réalisable 
et donne un rendement élevé pour le DM chez les patients TB. Le 
rendement de TB parmi les patients DM est faible et nécessite des 
recherches ultérieures utilisant des outils améliorés pour le diagnostic 
de la TB.
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Marco de referencia: Los consultorios de tuberculosis (TB) y diabetes 
(DM) en el Hospital Bowring y Lady Curzon, un centro de atención 
terciaria de Bangalore en la India.
Objetivo: Se buscó evaluar la factibilidad del cribado bidireccional 
de la TB y la DM y los resultados de esta intervención. 
Métodos: Fue este un estudio descriptivo realizado entre el 1° de 
marzo y el 30 de septiembre del 2012, en el cual se investigó en to-
dos los pacientes TB el diagnóstico de DM y vice versa. Una glucemia 
en ayunas igual o superior a 126 mg/dl determinó el diagnóstico de 
DM y entre 110 y 125 mg/dl definió el diagnóstico de prediabetes. 
Resultados: De los 510 pacientes con TB, 32 contaban con un di-
agnóstico previo de DM (6,3%). Con el cribado de los 478 pacientes 
restantes se estableció el diagnóstico de 15 casos de prediabetes 
(2,9%) y de 15 casos nuevos de DM (2,9%). Se observó una prevalen-
cia de DM más alta en los pacientes ⩾40 años de edad, los pacientes 
con TB pulmonar y los fumadores. Cuarenta y cinco de los 47 pacientes 
con TB y DM se inscribieron en el programa de atención de la DM. 
De los 1670 pacientes atendidos en las consultas de DM, en 45 se 
había establecido ya el diagnóstico de TB. De los 1625 pacientes re-
stantes que participaron en el cribado, 152 presentaban signos indic-
ativos de TB (9 %) y en dos de ellos se confirmó el diagnóstico. 
Conclusión: La detección sistemática bidireccional de la DM y la TB es 
factible y ofrece un alto rendimiento diagnóstico de casos de DM en 
los pacientes que sufren TB. El rendimiento diagnóstico del cribado de 
la TB en los pacientes DM fue bajo y se precisan nuevas investigaciones 
que utilicen instrumentos diagnósticos de la TB nuevos y mejorados.
 
 
